The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...
Credit: Otsuka. At this time, the product is available to patients for a discounted price of $50; the full price is $200. Rejoyn ™, the first prescription digital therapeutic cleared for the treatment ...
Rejoyn is a medical device designed as a phone app that targets major depressive disorder. Photo by NordWood Themes on Unsplash The U.S. Food and Drug Administration (FDA) is allowing the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback